Friday May 3
Supplement builds strength in fibromyalgia trial
Apart from helping with muscle weakness, though, the treatment had little effect on other symptoms of the mysterious disorder, such as chronic pain, fatigue, memory loss, depression, anxiety and sleeplessness.
Lyrica's New Role Could Pay Off Big For Pfizer Investors
Pfizer conducted an advanced study into the effects of its drug Lyrica, demonstrating that it is as effective as levetiracetam, Pfizer's own anti-seizure drug.
Lyrica (Epilepsy) - Forecast and Market Analysis to 2022 - New Market Study Published
GlobalData has released its new PharmaPoint Drug Evaluation report, "Lyrica - Forecast and Market Analysis to 2022". Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures.
Looking for Mr. Fibromyalgia
I have this funny habit of watching the evening network news with the television on mute.
Eisai - New Indication Approved in Japan for Lyrica Capsules
Release date- 28022013 - Pfizer Japan Inc. announced today that it has received approval in Japan to replace the current indication of peripheral neuropathic pain for pain treatment Lyrica Capsules with the new and broader indication of neuropathic pain.